Bedrocan develops its medical cannabis vaporizer
In a press release of the day, Dutch medical cannabis producer Bedrocan has announced the development of its cannabis vaporizer and the launch of tests with 20 patients.
An appeal was recently made in the Dutch media and via patient associations. Over 70 people applied for the study, which is designed to gather feedback on the ease of use of Bedrocan's new medical device. Their vaporizer will be marketed under the name Bedromedic®.
The aim of Bedromedic® is to enable healthy consumption of medical products based on cannabis. By heating cannabis below its combustion temperature, i.e. less than 220°C, the active plant ingredients are released in the form of steam.
The patient then inhales this vapour, which is absorbed by the body through the lungs. The process does not involve smoking, and allows you to take advantage of the medical benefits of cannabis without the harmful products of combustion.
The study will be carried out by Bedrocan's Research & Development department, which has selected the participants in advance. Participants will be prescribed Bedrocan medical cannabis by their doctor, and must have been treated with cannabis for at least 6 months, without having any experience of vaporization. They will have to test Bedromedic® at home and then fill in an online satisfaction questionnaire.
-
Business1 week ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the Netherlands4 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164


You must be logged in to post a comment Login